September 16, 2013: U.S. markets opened higher Monday morning after an announcement on Sunday by Larry Summers that he was withdrawing his name from consideration as the next chairman of the Federal Reserve. Summers was seen as more likely to end the Fed��s asset purchase program quickly than is Janet Yellen, who is now the betting favorite to be the new Fed chair. U.S. markets closed mixed as Apple Inc. (NASDAQ: AAPL) dragged the tech sector and the Nasdaq Composite down. Longer term, though, Apple might not look so bad.
Asian and European markets closed mostly higer today, while Latin American markets closed mixed.
Tuesday��s calendar includes the beginning of the two-day FOMC meeting and the following data releases and events (all times Eastern):
8:30 a.m. – Consumer price index 9:00 a.m. – Treasury international capital (TIC) data 10:00 a.m. – Housing market index 11:30 a.m. – 4- and 52-week bill auctionsHere are the closing bell levels for Monday:
Hot Shipping Stocks For 2016: Receptos Inc (RCPT)
Receptos, Inc. (Receptos), incorporated on June 9, 2008, is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics for immune disorders. The Company��s product candidates span three specialty disease areas. The Company��s lead asset, RPC1063, is being developed as an oral therapy for the treatment of relapsing multiple sclerosis (RMS) and inflammatory bowel disease (IBD). Its second asset, RPC4046, is being developed for the treatment of an allergic/immune-mediated disorder, eosinophilic esophagitis (EoE), which is an orphan disease. RPC1063 is an oral, once daily, selective and potent sphingosine 1-phosphate 1 receptor (S1P1R) modulator. RPC4046 is a monoclonal antibody selective to interleukin-13 (IL-13) and produced by recombinant deoxyribonucleic acid (DNA) technology.
As of December 31, 2012, RPC1063 was being tested in the Phase II portion of an accelerated design, randomized Phase II/III study for the treatment of RMS. In addition, Receptos has obtained special protocol assessment (SPA) agreement from the United States food and drug administration (FDA) on its clinical trial design for the planned Phase III portion of the Phase II/III study, as well as a second planned RMS Phase III study. RPC1063 is also being tested in a randomized Phase II study for the treatment of ulcerative colitis (UC), a gastrointestinal (GI) disea se.
As of December 31, 2012, the Company was enrolling a randomized Phase II study evaluating the ability of RPC1063 to induce clinical remission in patients with moderately-to-severely active UC called TOUCHSTONE. The Company��s second asset, RPC4046 for the treatment of EoE, builds upon its competencies in immunology and GI diseases. In-licensed from AbbVie Bahamas Ltd. and AbbVie Inc. (AbbVie) RPC4046 is a monoclonal antibody directed against the IL-13 target, which has been validated in Asthma, a predominantly allergic/immune-mediated disorder.
Advisors' Opinion:- [By Ben Levisohn]
Yes, say the folks at Nomura, who recommend buying�Celgene (CELG), Receptos
(RCPT), Gilead Sciences (GILD), Neurocrine Biosciences (NBIX), and Alexion Pharmaceuticals (ALXN), in that order. Analyst M. Ian Somaiya and team explain why: - [By Garrett Cook]
Receptos (NASDAQ: RCPT) shares shot up 46.35 percent to $99.14 after the company announced positive Phase 2 results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis.
- [By Garrett Cook]
Receptos (NASDAQ: RCPT) shares shot up 38.62 percent to $93.90 after the company announced positive Phase 2 results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis.
Top 10 Asian Companies To Watch For 2015: WisdomTree SmallCap Earnings Fund (EES)
WisdomTree SmallCap Earnings Fund (the Fund) seeks investment results that correspond to the price and yield performance of the WisdomTree SmallCap Earnings Index (the Index). The Index is a fundamentally weighted index that measures the performance of earnings-generating companies within the small-capitalization segment of the United States stock market. The Index consists of the companies in the bottom 25% of the market capitalization of the WisdomTree Earnings Index after the 500 largest companies have been removed. Companies must be incorporated and listed in the United States, and must have generated positive cumulative earnings over their most recent four fiscal quarters prior to the Index measurement date. The Index is earnings-weighted in December to reflect the proportionate share of the aggregate earnings each component company has generated. Companies with greater earnings generally have larger weights in the Index. Its investment advisor is WisdomTree Asset Management, Inc. Advisors' Opinion:- [By Philip Springer]
WisdomTree SmallCap Earnings Fund (EES) follows earnings generated by companies in the small-cap universe of the US stock market.
Furthermore, the fund looks to weight by earnings, giving bigger weights to firms that earn more, irrespective of market capitalization.
Top 10 Asian Companies To Watch For 2015: Blackbaud Inc.(BLKB)
Blackbaud, Inc. provides software and related services for nonprofit organizations. The company offers The Raiser?s Edge, a software application to manage constituent relationship management (CRM) and fundraising activity; Blackbaud CRM, a Web-based CRM solution that addresses the needs of mid-size, large, and federated chapter based nonprofit organizations; eTapestry, a software-as-a-service (SaaS) donor management and fundraising solution for smaller nonprofits; Blackbaud NetCommunity, an Internet marketing and communications tool to build interactive Websites and manage email marketing campaigns; Sphere eMarketing, a SaaS that provides applications to manage e-marketing, communications, programs, services, and online fundraising; Everyday Hero, an event-based online fundraising solution; and BlackbaudNow for developing an online presence and accepting online donations. It also provides The Financial Edge, an accounting application; The Education Edge, a student informa tion management system; Blackbaud?s Student Information System, which links student information across various campus offices, as well as organizes the admissions and registrar?s processes; and Blackbaud for Small Schools, a SaaS solution that helps schools with their registration process, as well as gives parents, students, and faculty an online access to school information. In addition, the company offers The Patron Edge, a ticketing management solution; Blackbaud Direct Marketing that helps in managing direct marketing campaigns with various media and channels; Sphere Friends Asking Friends software product to launch and manage online event fundraising Websites; and Altru, a SaaS solution that helps general admissions arts and cultural organizations in their operation. Further, it provides consulting and education, analytics, maintenance, and payment processing services. Blackbaud, Inc. was founded in 1981 and is headquartered in Charleston, South Carolina.
Advisors' Opinion:- [By Seth Jayson]
Blackbaud (Nasdaq: BLKB ) is expected to report Q1 earnings on May 1. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Blackbaud's revenues will expand 20.7% and EPS will expand 11.8%. - [By MONEYMORNING.COM]
Now we like Blackbaud Inc. (NasdaqGS: BLKB).
Charleston, S.C.-based Blackbaud focuses on such nonprofits as research foundations and universities. The company has 29,000 clients who use its software to manage fundraising, accounting, and online marketing and payment services.
Top 10 Asian Companies To Watch For 2015: BB&T Corp (BBT)
BB&T Corporation (BB&T) is a financial holding company. BB&T conducts its business operations primarily through its commercial bank subsidiary, Branch Banking and Trust Company (Branch Bank), which has offices in North Carolina, Virginia, Florida, Georgia, Maryland, South Carolina, Alabama, West Virginia, Kentucky, Tennessee, Texas, Washington D.C and Indiana. In addition, BB&T��s operations consist of a federally chartered thrift institution, BB&T Financial, FSB (BB&T FSB), and a number of nonbank subsidiaries, which offer financial services products. BB&T��s operations are divided into six business segments: Community Banking, Residential Mortgage Banking, Dealer Financial Services, Specialized Lending, Insurance Services, and Financial Services. Branch Bank provides a range of banking and trust services for retail and commercial clients in its geographic markets, including small and mid-size businesses, public agencies, local Governments and individuals, through 1,779 offices as of December 31, 2011. During the year ended December 31, 2011, BB&T announced the acquisitions of Liberty Benefit Insurance Services, Atlantic Risk Management Corporation and the Precept Group. In April 2012, it acquired the life and property and casualty insurance operating divisions of Roseland, New Jersey - based Crump Group Inc. On July 31, 2012, it acquired BankAtlantic.
As of December 31, 2011, the principal operating subsidiaries of BB&T included Branch Banking and Trust Company, Winston-Salem, North Carolina; BB&T Financial, FSB, Columbus, Georgia; Scott & Stringfellow, LLC, Richmond, Virginia; Clearview Correspondent Services, LLC, Richmond, Virginia; Regional Acceptance Corporation, Greenville, North Carolina; American Coastal Insurance Company, Davie, Florida, and Sterling Capital Management, LLC, Charlotte, North Carolina. Branch Bank��s principal operating subsidiaries include BB&T Equipment Finance Corporation, BB&T Investment Services, Inc., BB&T Insurance Services, Inc., Stanley, Hunt, DuPree! & Rhine (a division of Branch Bank), Prime Rate Premium Finance Corporation, Inc., Grandbridge Real Estate Capital, LLC, Lendmark Financial Services, Inc., CRC Insurance Services, Inc. and McGriff, Seibels & Williams, Inc.
Community Banking
BB&T��s Community Banking serves individual and business clients by offering a range of loan and deposit products and other financial services. As of December 31, 2011, Community Banking had a network of 1,779 banking.
Residential Mortgage Banking
Residential Mortgage Banking segment retains and services mortgage loans originated by Community Banking, as well as those purchased from various correspondent originators. Mortgage loan products include fixed and adjustable rate Government and conventional loans for the purpose of constructing, purchasing or refinancing residential properties. Substantially all of the properties are owner occupied. BB&T retains the servicing rights to all loans sold. Residential Mortgage Banking earns interest on loans held in the warehouse and portfolio, fee income from the origination and servicing of mortgage loans and recognizes gains or losses from the sale of mortgage loans. BB&T��s mortgage originations totaled $23.7 billion in 2011. BB&T��s residential mortgage servicing portfolio, which includes both retained loans and loans serviced for third parties, totaled $91.6 billion in 2011.
Dealer Financial Services
Dealer Financial Services originates loans to consumers on a prime and nonprime basis for the purchase of automobiles. Such loans are originated on an indirect basis through approved franchised and independent automobile dealers throughout the BB&T market area and nationally through Regional Acceptance Corporation. This segment also originates loans for the purchase of boats and recreational vehicles originated through dealers in BB&T��s market area. In addition, financing and servicing to dealers for their inventories is provided through a ! joint rel! ationship between Dealer Financial Services and Community Banking.
Specialized Lending
BB&T��s Specialized Lending consists of eight business units that provide specialty finance products to consumers and businesses. The internal business units include Commercial Finance that contains commercial finance and mortgage warehouse lending; and, Governmental Finance that is responsible for tax-exempt Government finance. Operating subsidiaries include BB&T Equipment Finance which provides equipment leasing within BB&T��s banking footprint; Sheffield Financial, a division of FSB Financial, a dealer-based financer of equipment for both small businesses and consumers; Lendmark Financial Services, a direct consumer finance lending company; Prime Rate Premium Finance Corporation, which includes AFCO and CAFO, insurance premium finance business units that provide funding to businesses in the United States and Canada and to consumers in certain markets within BB&T��s banking footprint, and Grandbridge Real Estate Capital, a commercial mortgage banking lender providing loans on a national basis.
Insurance Services
BB&T Insurance Services provides property and casualty, life and health insurance to businesses and individuals. It also provides small business and corporate products, such as workers compensation and professional liability, as well as surety coverage and title insurance. In addition, Insurance Services also underwrites a limited amount of property and casualty coverage.
Financial Services
Financial Services provides personal trust administration, estate planning, investment counseling, wealth management, asset management, employee benefits services, corporate banking and corporate trust services to individuals, corporations, institutions, foundations and Government entities. Financial Services also offers clients investment alternatives, including discount brokerage services, equities, fixed-rate and variable-rate annuiti! es, mutua! l funds and governmental and municipal bonds through BB&T Investment Services, Inc., a subsidiary of Branch Bank. Financial Services includes Scott & Stringfellow, LLC, a brokerage and investment banking firm. Scott & Stringfellow provides services in retail brokerage, equity and debt underwriting, investment advice, corporate finance and equity research and facilitates the origination, trading and distribution of fixed-income securities and equity products in both the public and private capital markets. Scott & Stringfellow also has a public finance department that provides investment banking services, financial advisory services and municipal bond financing. Scott & Stringfellow��s investment banking and corporate and public finance areas conduct business as BB&T Capital Markets. This segment includes BB&T Capital Partners that is a group of BB&T-sponsored private equity and mezzanine investment funds that invest in privately owned middle-market operating companies. Financial Services also includes the Corporate Banking Division that originates and services corporate relationships, syndicated lending relationships and client derivatives.
Advisors' Opinion:- [By Michael Flannelly]
Goldman Sachs analysts upgraded financial services company BB&T Corporation (BBT) on Tuesday because the stock offers an upside to earnings in a rising interest rate environment.
The analysts upgraded BBT from “Neutral” to “Buy” and see shares reaching $39, up from the previous target of $37. This new price target suggests a 13% upside to the stock’s Monday closing price of $34.48.
The analysts cited three main factors for the upgrade. For one, as mentioned above, BB&T offers an upside to earnings in a rising interest rate environment because it is leveraged to the long-end of the yield curve. Also, the analysts expect the company’s credit losses to continue to improve. Finally, the analysts expect BB&T’s loan growth to pick up.
Moreover, Goldman Sachs boosted BB&T’s fiscal 2013, 2014, and 2015 EPS estimates to $2.50, $3.22, and $3.55, respectively.
BB&T Corp shares were up 42 cents, or 1.22%, during pre-market trading on Tuesday. The stock is up 18.45% year-to-date.
- [By WWW.DAILYFINANCE.COM]
AlamyCitizens Bank ranks the No. 1 financial institution among baby boomers. Each stage of life brings with it a unique set of challenges to overcome and benchmarks to hit -- and this is especially true when it comes to banking. Although financial institutions target millennials heavily, baby boomers (Americans born between 1946 and 1964) are still the most represented generation among today's banking customers. A December Gallup poll revealed that 89 percent of baby boomers have at least one checking, savings or money market account. With more than 75 million baby boomers in the United States, there's a greater demand for financial institutions that cater to the boomer lifestyle. 3 Things Baby Boomers Need Most From Banks The youngest baby boomers have reached seniority in the labor force, while the oldest members of this generation have entered retirement. Both ends of the spectrum have vastly different circumstances when it comes to income, but no matter their age, boomers have three main banking needs. 1. Customer Service. Customer service comes in many forms, whether from an in-person associate at a brick-and-mortar branch or an attendant at a small kiosk in a local grocery store. Boomers have grown up with institutions that rely on real-life, person-to-person transactions that allow them to talk through terms and conditions and have questions addressed. Physical bank branches are necessary in order to fulfill this service expectation. As more financial institutions have turned to online and mobile banking, some baby boomers who are slow to adapt to banking technology have been isolated as a result. 2. Retirement Planning. With the average life span in the U.S. expanding each year, and so many baby boomers on the road to retirement, the need for retirement planning resources becomes more and more pressing for many banking customers. "In my experience, the most stressful situation that baby boomers encounter is the fear of running out of money d
- [By Shauna O'Brien]
Before Thursday’s opening bell, regional bank BB&T Corporation (BBT) reported higher first quarter earnings. Despite the increase in earnings, the company was unable to exceed analysts’ expectations.
BBT’s Earnings in Brief
BBT posted first quarter earnings of�$501 million, or 69 cents per share, up from�$210 million, or 29 cents per share, a year ago. Analysts expected to see earnings of 70 cents per share. Revenue for the quarter was�$2.29 billion, down from $2.46 billion last year and below analysts’ estimate of $2.31 billion. The bank reported that its loan portfolio rose 1.7% from the Q1 of last year.CEO Commentary
BBT’s chairman and CEO Kelly S. King had the following comments:�”Our results for the first quarter were solid in light of normal seasonality. Insurance revenues were very strong for the quarter, credit results continued to improve and expenses were down $53 million compared with last quarter, reflecting improving expense control. Commercial loan growth was strong, particularly commercial real estate lending for income producing properties. Consistent with industry trends, mortgage banking income declined as originations were down from last year’s record levels.”
BBT’s Dividend
BBT paid its last quarterly dividend of 23 cents on March 3. �The company reported that it is considering raising its dividend to 24 cents. We expect BBT to declare its next dividend sometime in April.
Stock Performance
BB&T Corporation shares were mostly flat during pre-market trading Thursday. The stock is up 5.41% YTD.
BBT Dividend SnapshotAs of market close of April 16, 2014
Click here to see the complete history of BBT dividends.
- [By Amanda Alix]
The best, and the worst
For the fourth year in a row, BB&T (NYSE: BBT ) has taken the top spot for the highest consumer approval rating among mortgage servicers -- scoring 765 out of a possible 1,000 points -- though it did register a drop from last year's grade of 803. At the very bottom of the pile, servicers Ocwen and Nationstar still reside: Ocwen improved by 36 points, though Nationstar lost 11 points.
Top 10 Asian Companies To Watch For 2015: Insys Therapeutics Inc (INSY)
Insys Therapeutics, Inc., incorporated on June 15, 1990, is a pharmaceutical company that develops and seeks to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The Company��s pharmaceuticals portfolio consists of one approved product and a number of product candidates targeting cancer-supportive care and cancer therapy. The Company��s product candidate includes Subsys, Dronabinol SG Capsule, Dronabinol RT Capsule, Dronabinol Oral Solution, Dronabinol Inhalation Device, and Dronabinol IV Solution. The Company is also developing cancer therapeutics, which is LEP-ETU, a formulation of paclitaxel, the active ingredient in the cancer drugs Taxol and Abraxane. On August 19, 2011, the Food & Drug Administration (FDA) approved its Dronabinol SG Capsule product, a generic equivalent to Marinol, for the treatment of chemotherapy induced nausea and vomiting (CINV), and anorexia associated with weight loss in patients with acquired immune deficiency syndrome (AIDS).
Subsys
The Company's Subsys is a single-use product that delivers fentanyl, an opioid analgesic, in seconds for transmucosal absorption underneath the tongue. Subsys is a transmucosal product to show pain relief when measuring the sum of pain intensity difference at five minutes in a Phase 3 breakthrough cancer pain (BTCP) clinical trial using fentanyl.
Dronabinol Product Family
The Company has an approved dronabinol product and is developing several dronabinol product candidates for the treatment of CINV and appetite stimulation in patients with AIDS, as well as other indications where dronabinol could have potential therapeutic benefits. Dronabinol, the active ingredient in Marinol, is a synthetic cannabinoid whose chemical name is delta-9-tetrahydrocannabinol (THC). Its portfolio consists of its Dronabinol SG Capsule product and Dronabinol RT Capsule product candidate, which are intended to be generic equi! valents to Marinol, in addition to three formulations, including Dronabinol Oral Solution. Dronabinol SG Capsule is a dronabinol soft gelatin capsule intended to be a generic equivalent to Marinol. Dronabinol RT Capsule is a dronabinol soft gel capsule that is stable at room temperature. Dronabinol Oral Solution is a ynthetic THC in an oral liquid formulation.
Cancer Therapeutics
In addition to its cancer-supportive care products, the Company intends to develop cancer therapeutics targeting limitations of existing commercial products. LEP-ETU, it advanced cancer therapeutic, is a NeoLipid liposomal, or microscopic membrane-like structure created from lipids, formulation that incorporates paclitaxel. LEP-ETU completed a Phase 2 clinical trial of 70 patients with metastatic breast cancer.
The Company competes with Cephalon, Inc., BioDelivery Sciences International, Inc., ProStrakan Group plc, Nycomed International Management GmbH, Archimedes Pharma Ltd., TEVA Pharmaceuticals USA, Watson Pharmaceuticals, Inc., AcelRx Pharmaceuticals, Inc., Akela Pharma Inc., Abbott Laboratories, Pharmaceutical International, Inc., Par Pharmaceutical Companies Inc., sanofi-aventis, Eisai Inc., Helsinn Group, Roche Holding AG, Par Pharmaceutical Companies Inc., GlaxoSmithKline plc, ProStrakan Group plc, Merck & Co, GW Pharmaceutical, A.P. Pharma, Inc., Aphios Corp., Roche Holding, Tesaro, Inc., Cornerstone Pharmaceutical, Inc., Bristol-Myers Squibb, Celgene Corporation, Laboratories, Amgen Inc., AstraZeneca PLC., Bayer AG, Biogen Idec Inc., Eisai Co., Ltd., F. Hoffmann- LaRoche Ltd., Johnson and Johnson, Merck and Co., Inc., Novartis AG, Onyx Pharmaceuticals Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.
Advisors' Opinion:- [By Monica Gerson]
INSYS Therapeutics (NASDAQ: INSY) is projected to report its Q1 earnings at $0.28 per share on revenue of $45.63 million.
Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets
- [By Roberto Pedone]
One specialty pharmaceutical player that's quickly moving within range of triggering a big breakout trade is Insys Therapeutics (INSY), which develops and commercialize supportive care products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. This stock is off to a monster start in 2013, with shares up a whopping 434%.
>>5 Stocks Insiders Love Right Now
If you take a look at the chart for Insys Therapeutics, you'll notice that this stock has been uptrending strong for the last six months, with shares soaring higher from its low of $9.30 to its recent high of $53.64 a share. During that uptrend, shares of INSY have been making mostly higher lows and higher highs, which is bullish technical price action. Shares of INSY have recently pulled back to its 50-day moving average and the stock has now started to spike higher off that level. That spike is starting to push shares of INSY within range of triggering a big breakout trade.
Traders should now look for long-biased trades in INSY if it manages to break out above some near-term overhead resistance levels at $43.50 to $44.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 235,266 shares. If that breakout hits soon, then INSY will set up to re-test or possibly take out its next major overhead resistance levels at $47.25 to its all-time high at $53.64 a share.
Traders can look to buy INSY off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $38.75 a share or near its 50-day at $36.73 a share. One can also buy INSY off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Jake L'Ecuyer]
INSYS Therapeutics (NASDAQ: INSY) was also down, falling 15.14 percent to $27.73 after news broke that a doctor had fraudulently prescribed its drug Subsys.
- [By Matt Jarzemsky]
Among companies that went public in the U.S. last year, FireEye has seen the second-biggest share rally since its IPO, trailing only pharmaceutical company Insys Therapeutics Inc.(INSY)
Top 10 Asian Companies To Watch For 2015: China Jo-Jo Drugstores Inc.(CJJD)
China Jo-Jo Drugstores, Inc. owns and operates a retail pharmacy chain in the People?s Republic of China. Its stores sell various medicinal products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicine products, personal care products, family care products, and medical devices, as well as convenience products including consumable, seasonal, and promotional items. The company also has licensed doctors, who provide consultation, examination, and treatment of common ailments. In addition, its stores include medical clinics that offer urgent care, traditional Chinese medicines, and minor outpatient surgical treatments. The company operates a chain of approximately 55 drugstores under the Jiuzhou Grand Pharmacy Quannuo Grand Pharmacy, and Lydia Grand Pharmacy brand names. The company is headquartered in Hangzhou, the People?s Republic of China.
Advisors' Opinion:- [By Bryan Murphy]
Although the market seems to be losing traction, and even losing ground now, the same can't be said of every single stock. A handful of stocks like China Jo-Jo Drugstores Inc. (NASDAQ:CJJD), Vuzix Corp. (OTCBB:VUZI), and Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) are forging ahead, doling out gains against the grain. Not that moving higher while other names are moving lower is a sure sign that ADMP, VUZI, and CJJD will remain in their uptrends indefinitely, but it sure doesn't hurt their odds. Here's a closer look at each one and why you'd want to add them to your watchlist.
- [By Roberto Pedone]
Another under-$10 drug retailer that's starting to move within range of triggering a big breakout trade is China Jo-Jo Drugstores (CJJD), which operates as a retailer and distributor of pharmaceutical and other health care products in the People's Republic of China. This stock has been on fire for the last three months, with shares ripping higher by 46%.
If you take a look at the chart for China Jo-Jo Drugstores you'll notice that this stock has been uptrending strong over the last month and change, with shares moving higher from its low of 65 cents per share to its recent high of $1.18 a share. During that uptrend, shares of CJJD have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CJJD within range of triggering a big breakout trade above some near-term and past overhead resistance levels.
Market players should now look for long-biased trades in CJJD if it manages to break out above some near-term overhead resistance at $1.18 a share and then once it clears some past overhead resistance levels at $1.21 to $1.32 a share high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 99,122 shares. If that breakout hits soon, then CJJD will set up to re-test or possibly take out its next major overhead resistance levels at $1.70 to its 52-week high at $1.99 a share.
Traders can look to buy CJJD off weakness to anticipate that breakout and simply use a stop that sits just below its 50-day moving average of 98 cents per share. One can also buy CJJD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top 10 Asian Companies To Watch For 2015: Hasbro Inc.(HAS)
Hasbro, Inc. engages in the design, manufacture, and marketing of games and toys. The company principally provides children?s and family leisure time and entertainment products and services. It offers various games, including traditional board, card, hand-held electronic, trading card, roleplaying, and DVD games, as well as electronic learning aids and puzzles. Hasbro?s toy products include boy?s action figures, vehicles and playsets, girl?s toys, electronic toys, plush products, preschool toys and infant products, electronic interactive products, creative play products, and toy related specialty products. The company also licenses certain of its trademarks, characters, and other property rights to third parties for use in connection with consumer promotions and for the sale of noncompeting toys and games, and non-toy products. It offers its products primarily under PLAYSKOOL, TRANSFORMERS, NERF, MY LITTLE PONY, LITTLEST PET SHOP, TONKA, G.I. JOE, SUPER SOAKER, MILTON BRAD LEY, PARKER BROTHERS, CRANIUM, AVALON HILL, TIGER, FURREAL FRIENDS, BABY ALIVE, STRAWBERRY SHORTCAKE, and WIZARDS OF THE COAST brand names. The company markets its products to various customers, including wholesalers, distributors, chain stores, discount stores, mail order houses, catalog stores, department stores, and other retailers, as well as Internet-based e-tailers. It has a strategic licensing agreement with Electronic Arts Inc. (EA), which provides EA with the worldwide rights to create digital games for various platforms, including mobile phones, personal computers, and game consoles, as well as; and a strategic relationship with Universal Pictures to produce approximately three motion pictures based on certain of company?s brands. Hasbro sells its products through its own sales force and distributors primarily in the United States, Canada, Mexico, Europe, the Asia Pacific, Latin America, and South America. The company was founded in 1923 and is headquartered in Paw tucket, Rhode Island.
Advisors' Opinion:- [By Peter Graham]
The Q3 2014 earnings report for large cap toy stock Mattel, Inc (NASDAQ: MAT), a potential peer of mid cap�Hasbro, Inc (NASDAQ: HAS) and small cap JAKKS Pacific, Inc (NASDAQ: JAKK), is scheduled for before the market opens on Thursday (October 16th). Aside from the Mattel, Inc earnings report, it should be said that Hasbro, Inc will report Q3 2014 earnings on October 20th (Next Monday)�before the market opens while�JAKKS Pacific, Inc will report Q3 2014 earnings before the market opens on October 23rd (Thursday). Mattel, Inc, like other toy stocks, has struggled to remain relevant in an age when many kids prefer to play video, mobile and computer games rather than with physical toys.
- [By Rick Munarriz]
Mattel's results were merely flat -- and it simply earned less than analysts were targeting instead of shocking the pros with a deficit -- but these gloomy reports can't be comforting for Hasbro (NASDAQ: HAS ) investors.
